[Receptor scintigraphy in endocrine gastrointestinal and pancreatic tumors].
Joseph
K
K
Abteilung für Klinische Nuklearmedizin, Universität Marburg.
Stapp
J
J
Reinecke
J
J
Höffken
H
H
Benning
R
R
Neuhaus
C
C
Trautmann
M E
ME
Schwerk
W B
WB
Arnold
R
R
D000328:Adult; D005260:Female; D015408:Gastrinoma / Q000000981:diagnostic imaging*; D006801:Humans; D007340:Insulinoma / Q000000981:diagnostic imaging*; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000000981:diagnostic imaging*; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000000981:diagnostic imaging; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D017981:Receptors, Neurotransmitter / Q000032:analysis*; D017481:Receptors, Somatostatin; D013004:Somatostatin / Q000032:analysis*; D015043:Zollinger-Ellison Syndrome / Q000000981:diagnostic imaging*
D017981:Receptors, Neurotransmitter; D017481:Receptors, Somatostatin; D013004:Somatostatin
Rezeptorszintigraphie bei endokrinen gastroenteropankreatischen Tumoren.